Filtered By:
Source: Stroke
Condition: Atrial Fibrillation

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 257 results found since Jan 2013.

Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012 Clinical Sciences
Conclusions— This study describes the burden of TIA in an era of aggressive primary and secondary vascular risk factor management. Education programs for medical practitioners and patients around the identification and management of atrial fibrillation are required.
Source: Stroke - August 21, 2016 Category: Neurology Authors: Barber, P. A., Krishnamurthi, R., Parag, V., Anderson, N. E., Ranta, A., Kilfoyle, D., Wong, E., Green, G., Arroll, B., Bennett, D. A., Witt, E., Rush, E., Minsun Suh, F., Theadom, A., Rathnasabapathy, Y., Te Ao, B., Parmar, P., Feigin, V. L., for the ARC Tags: Epidemiology, Race and Ethnicity, Risk Factors, Cerebrovascular Disease/Stroke, Transient Ischemic Attack (TIA) Clinical Sciences Source Type: research

Stratifying Stroke Risk in Atrial Fibrillation Focused Updates in Cerebrovascular Disease
Source: Stroke - September 25, 2017 Category: Neurology Authors: Shadi Yaghi, Hooman Kamel Tags: Cerebrovascular Disease/Stroke Focused Updates in Cerebrovascular Disease Source Type: research

Secondary Stroke Prevention in Atrial Fibrillation Editorials
Source: Stroke - May 25, 2018 Category: Neurology Authors: M. Edip Gurol Tags: Atrial Fibrillation, Secondary Prevention, Cerebrovascular Disease/Stroke Editorial Source Type: research

Imaging Characteristics of Ischemic Strokes Related to Patent Foramen Ovale Clinical Sciences
Conclusions— A PFO-stroke usually appears as a single cortical or multiple small ischemic lesions in the vertebrobasilar circulation without any visible vessel occlusion on angiography. The recanalization rate is significantly lower than in AF-stroke. These imaging characteristics of PFO-stroke may help to diagnose the mechanism and determine the treatment strategy.
Source: Stroke - November 25, 2013 Category: Neurology Authors: Kim, B. J., Sohn, H., Sun, B. J., Song, J.-K., Kang, D.-W., Kim, J. S., Kwon, S. U. Tags: Pediatric and congenital heart disease, including cardiovascular surgery, Acute Cerebral Infarction, Computerized tomography and Magnetic Resonance Imaging Clinical Sciences Source Type: research

A Prospective Cohort Study of Patients With Transient Ischemic Attack to Identify High-Risk Clinical Characteristics Clinical Sciences
Conclusions— Patients with TIA with their first TIA, language disturbance, duration of symptoms ≥10 minutes, gait disturbance, atrial fibrillation, infarction on computed tomography, elevated platelets or glucose, unilateral weakness, history of carotid stenosis, and elevated diastolic blood pressure are at higher risk for an impending stroke. Patients with vertigo and no high-risk features are at low risk. The Canadian TIA Score quantifies the impending stroke risk following TIA.
Source: Stroke - December 23, 2013 Category: Neurology Authors: Perry, J. J., Sharma, M., Sivilotti, M. L. A., Sutherland, J., Worster, A., Emond, M., Stotts, G., Jin, A. Y., Oczkowski, W. J., Sahlas, D. J., Murray, H. E., MacKey, A., Verreault, S., Wells, G. A., Stiell, I. G. Tags: Transient Ischemic Attacks Clinical Sciences Source Type: research

Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation: A Secondary Analysis of the AVERROES Study Brief Reports
Conclusions— Female patients with atrial fibrillation had higher ischemic stroke rates compared with male patients, but the relative effects of apixaban compared with aspirin on both ischemic stroke and bleeding were similar in men and women.
Source: Stroke - June 23, 2014 Category: Neurology Authors: Lip, G. Y. H., Eikelboom, J., Yusuf, S., Shestakovska, O., Hart, R. G., Connolly, S., on behalf of the AVERROES Investigators Tags: Other anticoagulants, Thrombosis risk factors Brief Reports Source Type: research

Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation Clinical Sciences
Conclusions— Among patients with previous ischemic stroke or transient ischemic attack, those with sustained AF had a higher risk of stroke or systemic embolism compared with those with paroxysmal AF. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01581502.
Source: Stroke - September 25, 2016 Category: Neurology Authors: Koga, M., Yoshimura, S., Hasegawa, Y., Shibuya, S., Ito, Y., Matsuoka, H., Takamatsu, K., Nishiyama, K., Todo, K., Kimura, K., Furui, E., Terasaki, T., Shiokawa, Y., Kamiyama, K., Takizawa, S., Okuda, S., Okada, Y., Kameda, T., Nagakane, Y., Yagita, Y., K Tags: Atrial Fibrillation, Secondary Prevention, Quality and Outcomes Clinical Sciences Source Type: research

Trends in Incidence and Early Outcomes in a Black Afro-Caribbean Population From 1999 to 2012: Etude Realisee en Martinique et Centree sur l'Incidence des Accidents Vasculaires Cerebraux II Study Clinical Sciences
Conclusions— Over 13 years, there has been a significant decrease (30.6%) in the age-specific first-ever stroke incidence in our Afro-Carribean population. Although prevention policies seem effective, we need to focus on new risk factors limitation and on male population adherence to prevention program.
Source: Stroke - October 27, 2014 Category: Neurology Authors: Olindo, S., Chausson, N., Mejdoubi, M., Jeannin, S., Rosillette, K., Saint-Vil, M., Signate, A., Edimonana-Kaptue, M., Larraillet, V., Cabre, P., Smadja, D., Joux, J. Tags: Acute Cerebral Hemorrhage, Acute Cerebral Infarction Clinical Sciences Source Type: research

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 Clinical Sciences
Conclusions— In patients with atrial fibrillation, once-daily edoxaban was as effective as warfarin in preventing all strokes, with significant reductions in various subtypes of intracranial bleeding. Ischemic cerebrovascular event rates were similar with high-dose edoxaban and warfarin, whereas low-dose edoxaban was less effective than warfarin. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00781391.
Source: Stroke - July 28, 2014 Category: Neurology Authors: Giugliano, R. P., Ruff, C. T., Rost, N. S., Silverman, S., Wiviott, S. D., Lowe, C., Deenadayalu, N., Murphy, S. A., Grip, L. T., Betcher, J. M., Duggal, A., Dave, J., Shi, M., Mercuri, M., Antman, E. M., Braunwald, E., on behalf of the ENGAGE AF-TIMI 48 Tags: Other anticoagulants, Acute Cerebral Hemorrhage, Acute Cerebral Infarction, Arrhythmias, clinical electrophysiology, drugs Clinical Sciences Source Type: research

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation Clinical Sciences
Conclusions—Upfront procedure costs initially make LAAC higher cost than warfarin and the non–vitamin K antagonist oral anticoagulants, but within 10 years, LAAC delivers more quality-adjusted life years and has lower total costs, making LAAC the most cost-effective treatment strategy for secondary prevention of stroke in atrial fibrillation.
Source: Stroke - May 25, 2018 Category: Neurology Authors: Vivek Y. Reddy, Ronald L. Akehurst, Stacey L. Amorosi, Meghan B. Gavaghan, Deanna S. Hertz, David R. Holmes Jr Tags: Atrial Fibrillation, Cost-Effectiveness Original Contributions Source Type: research

Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation Clinical Sciences
Conclusions— In majority of patients who receive antithrombotic agents, treatment is initiated within 6 months of ICH. Still, many patients with compelling indications for antithrombotic treatment are not prescribed antithrombotic agents. Factors other than high risk of embolic stroke by CHA2DS2-VASc in ICH survivors with concurrent AF are used to guide the anticoagulant treatment decision in Swedish clinical practice.
Source: Stroke - July 27, 2015 Category: Neurology Authors: Pennlert, J., Asplund, K., Carlberg, B., Wiklund, P.-G., Wisten, A., Asberg, S., Eriksson, M. Tags: Acute Cerebral Hemorrhage, Anticoagulants, Antiplatelets, Epidemiology Clinical Sciences Source Type: research

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation Clinical Sciences
Conclusions—In real-world practice among a high-risk Asian atrial fibrillation population, all 3 NOACs demonstrated similar risk of ischemic stroke and lower risk of ICH compared with warfarin. All-cause mortality was significantly lower only with dabigatran and apixaban.
Source: Stroke - October 23, 2017 Category: Neurology Authors: Myung-Jin Cha, Eue-Keun Choi, Kyung-Do Han, So-Ryoung Lee, Woo-Hyun Lim, Seil Oh, Gregory Y.H. Lip Tags: Atrial Fibrillation Original Contributions Source Type: research

Grading and Interpretation of White Matter Hyperintensities Using Statistical Maps Clinical Sciences
Conclusions— We have generated a novel graphical WMH grading (Kim statistical WMH scoring) system, correlated to risk factors and adjusted for age/hypertension. Further studies are required to confirm whether the combined data set allows grading of WMH burden in individual patients and a tailored patient-specific interpretation in ischemic stroke-related clinical practice.
Source: Stroke - November 24, 2014 Category: Neurology Authors: Ryu, W.-S., Woo, S.-H., Schellingerhout, D., Chung, M. K., Kim, C. K., Jang, M. U., Park, K.-J., Hong, K.-S., Jeong, S.-W., Na, J.-Y., Cho, K.-H., Kim, J.-T., Kim, B. J., Han, M.-K., Lee, J., Cha, J.-K., Kim, D.-H., Lee, S. J., Ko, Y., Cho, Y.-J., Lee, B. Tags: Acute Cerebral Infarction, Cerebral Lacunes, Computerized tomography and Magnetic Resonance Imaging Clinical Sciences Source Type: research

Prolonged QTc Interval Predicts Poststroke Paroxysmal Atrial Fibrillation Clinical Sciences
Conclusions— The QTc interval prolongation is potentially a strong and useful predictor for poststroke PAF.
Source: Stroke - December 22, 2014 Category: Neurology Authors: Hoshino, T., Nagao, T., Shiga, T., Maruyama, K., Toi, S., Mizuno, S., Ishizuka, K., Shimizu, S., Uchiyama, S., Kitagawa, K. Tags: Acute Cerebral Infarction Clinical Sciences Source Type: research

Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin Brief Reports
Conclusion— Anticoagulated female patients with atrial fibrillation had a similar rate of cardiovascular death and SSE, but a lower risk of major bleeding, compared with males. TTR (but not female sex) was an independent predictor for combined cardiovascular death and SSE and clinically relevant bleeding events.
Source: Stroke - May 22, 2016 Category: Neurology Authors: Senoo, K., Lip, G. Y. H. Tags: Quality and Outcomes Brief Reports Source Type: research